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Summary
Foot and mouth disease (FMD) is a highly contagious viral disease that affects all Artiodactyla. 
Seven immunologically distinct serotypes of FMD virus (FMDV) exist. In Chad, although FMD is 
included in the list of diseases monitored by the Chadian Animal Disease Surveillance Network 
(REPIMAT), the epidemiological situation remains unclear. A serological survey was conducted 
in the cattle population in eight of the nine administrative regions of the country (those regions 
with the highest cattle densities), to evaluate the prevalence and serotypes of circulating FMDV. 
A total of 796 sera from randomly selected cattle were analysed at the World Organisation 
for Animal Health/Food and Agriculture Organization of the United Nations FMD Reference 
Laboratory at the Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna 
(IZSLER), in Brescia (Italy). An enzyme-linked immunosorbent assay (ELISA), called 3ABC ELISA, 
was used to detect antibodies against non-structural proteins (NSPs), as well as a series of six 
competitive ELISAs to detect and serotype antibodies against the structural proteins of FMDV 
serotypes O, A, SAT 1, SAT 2, Asia 1 and C.
Based on the detection of anti-NSP antibodies, the animal-level seroprevalence was 35.6% 
(95% confidence interval [CI]: 32.2–38.9) and the herd-level seroprevalence was 62.3% (95% 
CI: 53.0–71.5). FMD was present in all livestock administrative divisions surveyed, with a higher 
prevalence in southern regions, which are characterised by higher rainfall and humidity and 
more important transboundary animal movements. Cattle aged more than four years had a 
higher seroprevalence, which may be due to repeated exposure. Semi-sedentary farming and 
transhumance were also risk factors. Antibodies against serotypes A, O, SAT 1 and SAT 2 were 
detected.
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Introduction
Livestock are an important source of income in most 
developing countries. In Africa, they often contribute up 
to 10–20% of the gross national product (1). In Chad, 
livestock contribute 80% of the agricultural capital stock 
(US$ 6,912 million in 2007), i.e. 59.1% of livestock fixed 
assets, 10.4% of livestock inventory, and 10.7% of structures 
for livestock (2). In Chad, the rural population represents 
72.4% of the whole population and livestock is the second-
largest source of foreign exchange earnings after oil (3). The 
livestock sector provides a livelihood for 40% of the rural 
population and accounts for 30% of Chad’s exports (over 
50%, excluding oil). Annual revenue streams in this sector 
are estimated at US$ 257 million (4). The livestock system 
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is pastoral and based on mobility. This system is used for 
80% of the cattle population (3). Animal diseases remain 
one of the major constraints to the development of this 
sector, including foot and mouth disease (FMD) (5, 6).
Foot and mouth disease is a highly contagious, transboundary, 
viral disease, affecting both domestic and wild Artiodactyla 
(7, 8, 9). There are seven serotypes (O, A, C, SAT 1, SAT 2, 
SAT 3 and Asia 1) and several subtypes with a worldwide 
distribution (10, 11, 12). Only five of the seven serotypes 
occur on the African continent. Serotype Asia 1 has not been 
observed in Africa and serotype C is extinct, in that it has 
not been seen for more than 14 years (13).
Foot and mouth disease is one of the major transboundary 
diseases, responsible for causing considerable economic 
losses, not only when it (re-)emerges in previously disease-
free areas but also in areas to which it is endemic (9, 13, 14, 
15, 16). Clinically, FMD is characterised by pyrexia (up to 
42°C), dullness, the presence of blisters and inappetence. 
In cattle, FMD is characterised by fever, a drop in milk 
production, and vesicles or blisters that appear in the mouth, 
on the teats and between the hooves. Hypersalivation, 
difficulty in swallowing, acute lameness and/or difficulty in 
walking accompany the lesions.
In epidemiological terms, FMD reaches morbidity of close 
to 100% and a mortality rate of about 5% when it (re-)
emerges in disease-free areas. Mortality usually takes place 
in young animals as a result of myocarditis, so-called ‘tiger 
heart disease’ (17).
Antibodies are found in a large proportion of animals 
kept under extensive husbandry, a production system 
characteristic of most countries in western and central 
Africa. Since FMD causes more losses in intensive husbandry 
systems, such as intensive dairy farms on the periphery 
of towns, these farms are usually targeted for vaccination 
campaigns (18).
A more accurate knowledge of the epidemiology and impact 
of FMD in traditional farming systems in sub-Saharan 
Africa is a prerequisite when evaluating and adapting 
control programmes, such as those advocated by the World 
Organisation for Animal Health (OIE) and the Food and 
Agriculture Organization of the United Nations (FAO) 
(19, 20). According to the World Reference Laboratory for 
FMD (WRLFMD) at the Pirbright Institute (www.wrlfmd.
org), there are few historical accounts of FMD outbreaks in 
Chad: serotype A was first reported in 1973 and serotype 
SAT 1 in 1963, 1964 and 1972. FMD has been included in 
the list of monitored diseases of the Chadian Animal Disease 
Surveillance Network since the Network’s creation in 1995 
(the Réseau d’Épidemiosurveillance des Maladies Animales 
au Tchad or REPIMAT). REPIMAT surveillance of FMD 
(6, 21) is passive and primarily targets cattle because of their 
importance to the country’s economy (21). FMD is the most 
reported disease to REPIMAT (5). However, the national 
laboratory is unable to analyse suspected FMD samples, due 
to a lack of trained personnel and the necessary equipment 
and materials. For this reason, FMD notification is limited 
to clinical suspicion without laboratory confirmation (6). 
The epidemiological situation of the disease thus remains 
unclear in the absence of any identification of FMDV 
serotype(s) circulating in the country. There has never been 
any FMD vaccination in Chad.
This present retrospective aims to evaluate the 
seroprevalence of FMD and assess the presence of specific 
antibodies directed against FMDV serotypes in Chad in 
early 2010, based on randomised historical serum samples.
Materials and methods
Survey area and sampling design
Chad has three main regions: a desert zone in the north, an 
arid Sahelian belt in the centre and a more fertile Sudanian 
savanna zone in the south. The survey area is depicted 
in Figure 1. Most herders are mobile pastoralists. Among 
the breeds of cattle raised in Chad are the white Fulani, 
red Fulani, white Lake Chad, Tupuri and Sokoto (22).
Two-stage random sampling was conducted to 
gather samples. The primary unit was the village (an 
epidemiological unit equivalent to the herd in the African 
context; i.e. with an absence of fences) and the secondary 
unit was the individual animal. 
A total of 106 villages were randomly drawn from the 
3,297 villages in the study area (involving eight breeding 
delegations) (Fig. 1). These villages were distributed over 
various geographic areas which were covered by 34 active 
REPIMAT surveillance posts. This should make it possible 
to detect herd seroprevalence of FMD of 50% (no a priori 
knowledge is available), with an absolute precision of 
10% and a confidence level of 95% (plus a reserve of 10% 
of samples in case some breeders declined to take part). 
The regional livestock delegation from the north was not 
included in this survey because the surveillance posts were 
no longer functional due to a lack of agents. In addition, this 
area is largely desert and cattle breeding here is of relatively 
low importance compared to in other delegations. 
An average of seven to eight cattle per village were randomly 
selected from animals aged one year and over, of both sexes. 
No vaccination against FMD has been carried out in Chad 
so far. A total of 796 randomly selected cattle were sampled 
without gender stratification; 628 were between one and 
four years old and 168 were more than four years of age.
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 Posts became non-functional in the northern delegation and were not retained (n = 2) 
 Functional surveillance posts that did not participate in sampling for this study (n = 72)
 Functional surveillance posts that participated in sampling for this study (n = 34) from 106 
villages, randomly drawn from 3,277 villages in total. These 106 villages are distributed across 
various geographical areas, covered by 34 active surveillance posts. 
 Capital of Chad
Fig. 1 
Location of the 106 Chadian Animal Disease Surveillance 
Network posts, by livestock administrative division
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Blood collection
Blood sampling was conducted between December 2009 
and February 2010. Jugular vein blood was collected 
in 5-ml Vacutainers®. Samples were kept at an ambient 
temperature for two to three hours to induce clotting. After 
removal of the coagulate, the serum was preserved on ice 
until its arrival at the Institut de Recherche en Élevage pour 
le Développement, in N’Djamena (Farcha Laboratory). The 
samples were centrifuged at 3,000 revolutions per minute 
(rpm), aliquoted in cryotubes (Nalgenes®) and stored at 
–20°C until transportation to the laboratory where analysis 
was carried out. The international requirements imposed 
on the transport of dangerous infectious materials were 
strictly adhered to during transportation from Chad to the 
analysing laboratory in Italy.
Serological testing
The samples were analysed at the Istituto Zooprofilattico 
Sperimentale della Lombardia e dell’Emilia Romagna 
(IZSLER), in Brescia, Italy, an OIE/FAO FMD Reference 
Centre.
The tests, developed at IZSLER, consisted of: 
– an ELISA for the detection of antibodies against NSPs, 
abbreviated in the text as the ‘3ABC ELISA’. Antibodies are 
elicited after an infection and are common to all FMDV 
serotypes
– a series of six ‘in-house’ competitive ELISAs for the 
detection and serotyping of antibodies against the structural 
proteins (SPs) of FMDV serotypes O, A, SAT 1, SAT 2, Asia 
1 and C, to indirectly identify the viral serotypes circulating 
in Chad. IZSLER did not test for SAT 3. 
Non-structural protein enzyme-linked immunosorbent 
assay
The serological assay used to detect anti-NSP antibodies 
was the previously validated 3ABC-trapping ELISA (23), 
in the form of a ready-to-use kit, with pre-sensitised 
ELISA immunoplates, peroxidase-conjugated anti-
ruminant immunoglobulin G (IgG), control sera, and 
the 3,3’,5,5’-tetramethylbenzidine chromogen, produced 
at IZSLER. The specificity of this NSP ELISA exceeds 
99%, while sensitivity varies, depending on the time lapse 
after infection and on previous vaccination status. Sensitivity 
of 100% can be achieved for non-vaccinated cattle exposed 
to infection, while 86.4% can be achieved for the detection 
of carriers among vaccinated cattle (23).
Monoclonal antibody-based, solid-phase, competitive, 
enzyme-linked immunosorbent assay 
The principle behind and the procedure for the monoclonal 
antibody (MAb)-based, solid-phase, competitive ELISA 
(SPCE) is described below. SPCEs were first used to quantify 
antibodies specific to the European FMDV subtypes O1, A5 
and C1 (24), and later applied to other infectious diseases 
(25, 26). Afterwards, the test reagents used for serotype O 
and A ELISAs, i.e. FMDV-specific MAbs and antigens, were 
adapted and validated to detect antibodies more closely 
related to currently used vaccine strains or circulating 
serotypes and variants. In particular, the updated ELISAs 
used FMDV antigens from the vaccine strains O1 Manisa 
and A22 Iraq. Each was respectively associated with a 
competing detector MAb characterised by broad intra-type 
reactivity. Similar ELISAs for the detection of antibodies 
against serotypes Asia 1, SAT 1 and SAT 2 have been 
described more recently (27, 28).
Briefly, the assay procedure for each SPCE was as follows: 
immunoplates were coated with 50 µl per well of a type-
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specific catching MAb at a saturating dilution in carbonate/
bicarbonate buffer of pH 9.6 by overnight incubation 
at 4°C. After three washes, 50 µl of FMDV antigen of 
the homologous serotype was placed in each well at a 
predetermined optimal dilution.
After 1 h of incubation at 37°C and washing, 50 µl of a 
series of three-fold dilutions of test and control sera was 
incubated with the trapped antigen for 1 h at 37°C. Then, 
25 µl per well of the homologous peroxidase-conjugated 
competitor/detector MAb was added to each well and 
plates were incubated at 37°C for a further 1 h. After a last 
series of washes, the colorimetric reaction was developed 
by distributing 50 µl per well of the substrate solution: 
0.5 mg/ml of o-phenylenediamine dihydrochloride (OPD) 
in phosphate-citrate buffer, pH 5, containing 0.02% H2O2.
The reaction was stopped after 10 min by adding 50 µl of 
2N H2SO4 and the optical density values (ODs) were read 
at a 492-nm wavelength. The optimal working dilution 
of antigen and peroxidase-conjugated MAb, giving a 
spectrophotometric reading of 1.5 OD, was predetermined 
by chequer-board titrations. The screening dilution for sera 
was 1/10; the endpoint titres of positive sera were expressed 
as the reciprocal of the highest serum dilution providing 
50% inhibition.
Statistical analysis
Data were entered into a spreadsheet using the program 
Microsoft Excel® 2010. Statistical analysis was carried out 
in Stata/MP 14.2 (29). A Poisson regression (or a negative 
binomial regression, when required, due to extra-binomial 
variability) was used, followed by a Bonferroni corrected 
multiple test, if appropriate. A chi-square test was used 
to test the association between management type and 
seroprevalence. A level of significance of 5% was used 
throughout (divided by the number of tests performed for 
the Bonferroni correction).
Results
Out of 796 samples tested in the 3ABC ELISA, 283 yielded 
a positive result, amounting to an animal seroprevalence 
of 35.6% (95% confidence interval [CI]: 32.2–38.9). The 
seroprevalence was geographically heterogeneous, varying 
significantly according to the livestock administrative 
division. The southern and central divisions showed a 
higher seroprevalence than the others. In addition, the East 
and Central East divisions showed a lower seroprevalence 
(less than 20%) than the other divisions (Table I). The 
overall average herd-level seroprevalence was 62.9% 
(95% CI: 53.0–71.5).
As shown in Table II, a significantly higher seroprevalence 
was recorded in older animals (p < 0.001).
Table III shows seroprevalence by production type. 
A significantly higher seroprevalence (chi square = 4.12, 
p = 0.042) was recorded in transhumant and semi-sedentary 
herds, compared to that found in sedentary herds.
Out of the 796 sera tested for antibodies against the SPs of 
six FMDV serotypes, 480 (60%) scored positive for one or 
more serotypes. In 278 positive sera, the FMDV serotype 
responsible for the infection was identified as type O, A, 
SAT 1 or SAT 2, based on the detection of antibody against 
a single serotype or antibody titres that were significantly 
higher against one serotype. Another 200 samples showed 
similar levels of antibodies against two or more serotypes 
Table I 
Seroprevalence of foot and mouth disease in Chad, by administrative division (antibodies against non-structural proteins)
Administrative 
division of Chad
Number of samples 
analysed
Number of positive 
samples
Prevalence (%) 95% CI Multi-test (a)
Centre 43 19 44.2 (29.4–59.0) ab
Centre-East 111 17 15.3 (8.6–22.0) cd
East 83 5 6.0 (0.9–11.1) D
North-West 126 38 30.2 (22.2–38.2) cd
West 87 21 24.1 (15.1–33.1) bcd
South 128 51 39.8 (31.3–48.3) ab
South-East 138 86 62.3 (54.2–70.4) A
South-West 80 46 57.5 (46.7–68.3) A
Total 796 283 35.6 (32.3–38.9)  
 
a) Regions with different letters are significantly different from each other (p < 0.05, with Bonferroni correction)
CI: confidence interval
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from O, A, SAT 1 or SAT 2 (Table IV). In contrast, the 
seropositivity levels for serotypes Asia 1 and C were very 
low (22 out of 296 sera tested weakly positive for FMDV 
Asia 1 and only six out of 796 tested borderline positive for 
type C) and could reasonably be attributed to cross-reactive 
antibodies.
Discussion
There is a clear need for FMD risk-based surveillance to 
determine the status and factors that influence disease 
dissemination in areas where FMD is endemic, such 
as African countries, and to target appropriate control 
strategies. Under the auspices of the FAO and OIE, some 
African regions have embarked on a progressive control 
pathway (PCP) for the control of FMD (20, 30). The 
success of any FMD control campaign depends on many 
factors (13):
– the specific epidemiology of the disease in areas of 
interest
– the local and regional surveillance programmes 
monitoring circulating FMDV
– a vaccine that includes strain(s) that antigenically match 
the circulating strain(s)
– the potency of the vaccine
– vaccine coverage
– rapid vaccine implementation
– the planning and management of the vaccination 
campaign by a well-resourced Veterinary Service
– the involvement and cooperation of livestock farmers.
Chad’s current status along the PCP for FMD is stage 0 
(on a scale ranging from 0 to 5), corresponding to an 
uncontrolled risk of FMD, with no reliable information 
(13, 20). Consequently, there is a crucial need for reliable 
epidemiological information on FMD in Chad, where the 
Table IV 
Prevalence of antibodies against foot and mouth disease serotypes in Chad, by administrative division 
Administrative 
division in Chad
Number of sera 
tested
Number of sera positive by serotype (a)




Number of sera that 
test negative for all 
serotypesO A SAT 1 SAT 2 (c)
Centre 43 13 1 4 2 4 19
Centre-East 111 13 0 20 3 5 70
East 83 7 0 18 4 4 50
North-West 126 8 10 13 10 27 58
West 87 3 11 13 2 8 50
South 128 5 15 16 15 39 38
South-East 138 6 11 5 19 77 20
South-West 80 9 17 2 3 36 13
Total (%) 796 64 (8.0 %) 65 (8.2%) 91 (11.4%) 58 (7.3%) 200 (25.1%) 318 (40%)
 
a) Positivity for a single serotype or antibody titre that is three-fold higher or more against a single serotype
b) Number of sera showing cross-reactivity for two or more serotypes
c) O, A, SAT 1 and SAT 2 are foot and mouth disease virus serotypes
Table III 
Seroprevalence of foot and mouth disease (antibodies against 
non-structural proteins), according to type of farm production 











Sedentary 690 236 34.2 (30.7–37.7)
Semi-sedentary 70 29 41.4 (29.9–53.0)
Transhumant 36 18 50.0 (33.7–66.3)
Total 796 283 35.6 (32.2–38.9) 
CI: confidence interval
Table II 
Seroprevalence of foot and mouth disease (antibodies against 










<4 years 628 191 30.4 (26.8–34.0)
>4 years 168 92 54.8 (47.2–62.3)
Total 796 283 35.6 (32.2–38.9) 
CI: confidence interval
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disease is endemic. As a result of the lack of local diagnostic 
laboratory expertise and the cost of reagents for FMD 
diagnosis, only clinical suspicions without laboratory 
confirmation are recorded by the surveillance network, 
REPIMAT (6).
The overall seroprevalence estimated in 2010 at the 
individual level (35.6%) and at the herd level (62.3%) 
highlights the gravity of FMDV circulation in Chad. 
Considering this high level of FMD seroprevalence and the 
common transhumant system in Chad (involving 80% of 
cattle), there is an important risk of spreading FMD through 
cattle movements over long distances (FMD ‘trans-pool’ 
movement). In consequence, at least two main options must 
be evaluated when attempting to control FMD. First, animal 
movement controls must be imposed to try to prevent the 
movement of FMDV. However, the practicality of this option 
is questionable as transhumance is an ancestral practice and 
increases the resilience of livestock (through the search for 
nutritive resources due to climatic conditions) and their 
associated population health. The second course of action 
is a vaccination campaign for livestock, but this requires a 
much better knowledge of the FMDV serotypes currently 
circulating throughout Africa, especially in countries that 
practise transhumance, to select the appropriate vaccine 
(thus requiring a regional approach to FMD control). In 
addition, more field information is needed on persistently 
infected carriers after vaccination. More transdisciplinary 
research (e.g. in anthropology, sociology, infectiology, 
epidemiology and economics) is also required to produce 
evidence-based information that will help decision-makers 
to choose the best option(s) for controlling FMD in Africa.
These high seroprevalence results, especially in the southern 
part of Chad, are probably due to a range of factors. Among 
them are:
– intense animal movements (80% of cattle are kept under 
a transhumant husbandry system), resulting in frequent 
contacts between different herds
– a more humid climate (rainfall of 800–1,200 mm/year), 
allowing longer virus survival outside the host
– the presence of wildlife (e.g. buffalo, antelope and 
warthogs), which can serve as reservoirs of the virus, in 
and around the numerous game reserves in the area (which 
generally have established boundaries but are not fenced).
Wildlife density is more important in the reserves to the 
south of the country, especially in Zakouma National 
Park. It is during the hot, dry season (March to April) that 
contact with livestock occurs frequently. This zone, rich 
in lush pastures, continuously has a high concentration of 
livestock, with herds coming from the whole of the Chadian 
territory, as well as from neighbouring countries (Cameroon 
and the Central African Republic) (11).
The role of game animals in the epidemiology 
of FMD has previously been investigated in Chad; in 
particular, in Zakouma National Park (12). In this study, 
blood samples from buffalo (n = 53) and other wildlife 
(n = 203) were collected from 1999 to 2003. Based on 
the detection of anti-NSP antibodies, the seroprevalence 
of FMD was estimated at 23.1% (mainly in Nile buffalo, 
Syncerus caffer aequinoctialis). Subsequently, the presence of 
specific antibodies against different serotypes of FMDV (A, 
O, C, SAT 1, SAT 2 and SAT 3) was evaluated in a subset 
of 30 sera, using SPCE. Positive responses were observed, 
in descending order, for serotypes SAT 2 (13/30), O (9/30), 
SAT 1 and C (2/30) (12).
The same serotypes found in the present study involving 
cattle were also recorded in a retrospective study by 
Di Nardo et al. (12), involving wildlife species (mainly 
buffalo). More investigations are needed to better 
understand the role of wildlife in FMD epidemiology in 
Chad. In addition, the lower seroprevalence observed in 
the East and Central East divisions is likely due to the low 
livestock density and fewer movements of animals in these 
areas.
The present study also shows a link between age 
and seroprevalence. Animals aged more than four years 
have a higher probability of being seropositive, probably 
due to a higher chance of having come into contact with 
the virus. A similar trend was observed in Ethiopia (31). 
While the inherent logic of this observation is obvious 
(by definition, older animals have had more opportunity 
to be exposed to FMDV during their lifetime), husbandry 
practices probably also have some influence. Young animals 
are kept around the camp while only older animals are 
trekked over long distances in search of pastures and water. 
This higher risk of being exposed to FMDV also means 
that older animals are more likely to become infected with 
different serotypes.
The results demonstrate the presence of serotypes A, O, SAT 1 
and SAT 2, while the very low levels of antibodies that react 
against serotypes Asia 1 and C are attributable to inter-type 
cross-reaction. In fact, ELISAs to detect antibodies against 
SPs suffer from imperfect type specificity, and cross-reactions 
may occur among all FMDV serotypes (32). However, the 
significantly higher proportion of sera that cross-react with 
two or more of the first four serotypes is also suggestive of 
multiple infections with different serotypes. Indeed, these 
four serotypes are regularly recorded in Africa (9, 14), 
where the diffusion of the various serotypes is essentially 
determined by uncontrolled animal movement (14).
The importance of husbandry is also reflected in the higher 
seroprevalence values obtained from transhumant and 
semi-sedentary herds, when compared to those of sedentary 
animals (Table III). This higher probability of exposure to 
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the virus also means that older animals harbour antibodies 
against a larger variety of serotypes, given that infection 
with one FMDV serotype does not protect against infection 
with other serotypes.
This is also reflected by the similar percentages of different 
serotypes observed in the results. In Cameroon, serotypes 
O, SAT 1 and SAT 2 have been identified (33). The global 
FMD situation is characterised by seven regional pools of 
dominant serotypes (11, 13). Chad is classified in the fifth 
pool, with serotypes A, O, SAT 1 and SAT 2. The authors’ 
results corroborate this classification. FMDV type C had a 
limited distribution compared to most of the other serotypes 
and has not been reported since 2004. Serotype Asia 1 has 
thus far never been reported in Africa (13). Serotype SAT 3 
is present only in pools 4 (East Africa) and 6 (South Africa), 
and geographically close to the countries comprising pool 5 
(West/Central Africa), which include Chad (11). Given the 
uncontrolled introduction of animals and animal products 
into Chad, the incursion of type SAT 3 cannot be ruled out. 
Further study of SAT 3 may be warranted, as this serotype 
has recently been recorded in sera from West and Central 
Africa (e.g. 34) and from eastern Africa (e.g. 35).
This study has some limitations that are worth mentioning. 
The principal shortcoming is the period of the study 
(late 2009 to early 2010) when no records on laboratory 
confirmation of FMD outbreaks could be found in the 
statistics of the Ministry of Agriculture and Livestock. The 
only laboratory findings confirming FMD outbreaks in Chad 
are those of the WRLFMD and the last confirmed date is in 
1973. A lack of local diagnostic laboratory expertise, the 
high cost of reagents for FMD diagnosis, a limited number 
of field staff, the cost of FMD vaccine, and the lack of a 
national and/or regional strategy for FMD surveillance and 
control are reasons frequently invoked (20). 
Since the present study, some interesting initiatives 
have been taken to improve the situation, including the 
establishment of a laboratory network with support from 
the European Commission (EC) for the Control of FMD 
(EuFMD); the organisation of training seminars for FMD 
laboratories in Mauritania, Niger and Chad in May 2012; 
and the provision of diagnostic kits (ELISAs) to each 
laboratory for local typing (20). Continuing such action 
(capacity-building, serological survey, isolating circulating 
FMDV strains) is strongly recommended in Chad and, more 
generally, across all of sub-Saharan Africa.
Despite such limitations, this study has clearly demonstrated 
the presence of antibodies directed against NSPs of FMDV 
in Chad, and shown that serotypes O, A, SAT 1 and 
SAT 2 were present there in 2010, on the basis of the 
prevalence of the serotype-specific antibodies identified. 
Epidemiological information obtained during this study has 
provided important insights for planning a control strategy. 
However, further similar studies are needed, including 
research into virus isolation and sequencing and studies 
of other highly sensitive species in Chad, including sheep, 
goats, pigs, camels and buffalo, if we are to come to a fuller 
understanding of the struggle against FMD.
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Résumé
La fièvre aphteuse est une maladie virale extrêmement contagieuse qui affecte 
l’ensemble des artiodactyles. Sept sérotypes du virus de la fièvre aphteuse ont été 
répertoriés, qui sont distincts au plan immunologique. Au Tchad, bien que la fièvre 
aphteuse figure sur la liste des maladies visées par le Réseau d’épidémiosurveillance 
des maladies animales du Tchad (REPIMAT), la situation épidémiologique demeure 
mal connue. Une enquête sérologique a été réalisée dans la population bovine de huit 
régions administratives sur les neuf que compte le pays (afin de couvrir les régions 
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Estudio de la seroprevalencia y determinación de serotipos 
de la fiebre aftosa en el Chad
M. Ouagal, E. Brocchi, S. Grazioli, A. Ben Youssef, K. Sumption, D. Kiram, 
A. Oussiguéré, P. Hendrikx, D. Berkvens & C. Saegerman
Resumen
La fiebre aftosa es una patología vírica muy contagiosa que afecta a todos los 
artiodáctilos. Existen siete serotipos inmunológicamente diferenciados del virus 
que la causa. En el Chad, aunque la fiebre aftosa figura en la lista de enfermedades 
sometidas a vigilancia por la Red Chadiana de Vigilancia Zoosanitaria (REPIMAT), 
la situación epidemiológica de la enfermedad sigue rodeada de incertidumbre. 
Los autores describen un estudio serológico realizado en la población vacuna de 
ocho de las nueve regiones administrativas del país (las que presentan la mayor 
densidad de ganado vacuno) con objeto de determinar la prevalencia y los serotipos 
del virus de la fiebre aftosa circulante. Tras seleccionar aleatoriamente un total de 
796 cabezas de ganado y obtener de ellas muestras de suero, estas fueron 
analizadas en el Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia 
Romagna (IZSLER) de Brescia (Italia), que es el Laboratorio de Referencia de la 
Organización Mundial de Sanidad Animal y la Organización de las Naciones Unidas 
para la Alimentación y la Agricultura para la fiebre aftosa. Para detectar anticuerpos 
dirigidos específicamente contra proteínas no estructurales se empleó un ensayo 
où la densité de la population bovine est la plus élevée), dans le but d’évaluer 
la prévalence du virus de la fièvre aphteuse et de caractériser les sérotypes 
présents. Au total, 796 sérums prélevés sur des bovins sélectionnés de manière 
aléatoire ont été analysés au Laboratoire de référence pour la fièvre aphteuse 
de l’Organisation mondiale de la santé animale/Organisation des Nations Unies 
pour l’alimentation et l’agriculture à l’Istituto Zooprofilattico Sperimentale della 
Lombardia e dell’Emilia Romagna (IZSLER) de Brescia (Italie). Les anticorps dirigés 
contre les protéines non structurales ont été détectés au moyen d’une épreuve 
immuno-enzymatique 3ABC (ELISA 3ABC) tandis qu’une série de six ELISA de 
compétition a permis de détecter et de caractériser les anticorps spécifiques des 
protéines structurales des sérotypes O, A, SAT 1, SAT 2, Asia 1 et C du virus de la 
fièvre aphteuse. 
D’après les résultats de la détection d’anticorps dirigés contre les protéines 
non structurales, la prévalence sérologique à l’échelle individuelle était de 
35,6 % (avec un intervalle de confiance [IC] à 95 % de 32,2 à 38,9) tandis que la 
prévalence à l’échelle des troupeaux s’élevait à 62,3 % (IC à 95 % de 53,0 à 71,5). 
La fièvre aphteuse était présente dans chacune des divisions administratives 
étudiées, avec une prévalence plus élevée dans les régions méridionales, 
qui se caractérisent par des précipitations et une hygrométrie plus fortes et 
par l’importance des mouvements transfrontaliers d’animaux. La prévalence 
sérologique était plus élevée chez les bovins âgés de plus de quatre ans, ce qui 
s’explique probablement par un nombre répété d’expositions. Le rôle de l’élevage 
semi-sédentaire et de la transhumance en tant que facteurs de risque a été mis 
en lumière. Les anticorps détectés étaient dirigés contre les sérotypes A, O, SAT 1 
et SAT 2. 
Mots-clés
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inmunoenzimático (ELISA) denominado ELISA 3ABC, a lo que se agregó una 
serie de seis técnicas ELISA de competición concebidas para detectar y tipificar 
anticuerpos dirigidos contra las proteínas estructurales de los serotipos O, A, 
SAT 1, SAT 2, Asia 1 y C del virus de la fiebre aftosa.
A tenor de los niveles detectados de anticuerpos contra proteínas no estructurales, 
la seroprevalencia individual era de un 35,6% (intervalo de confianza [IC] al 95%: 
32,2–38,9) y la seroprevalencia de rebaño era de un 62,3% (IC 95%: 53,0–71,5). 
La fiebre aftosa, presente en todas las divisiones administrativas ganaderas 
estudiadas, alcanzaba sus máximos niveles de prevalencia en las regiones 
meridionales, caracterizadas por tasas de pluviosidad y humedad más altas 
y por un mayor volumen de movimientos transfronterizos de animales. La 
seroprevalencia era más elevada en los ejemplares de más de cuatro años 
de edad, hecho que puede deberse a exposiciones reiteradas. La producción 
ganadera en régimen semisedentario y la trashumancia eran también factores de 
riesgo. Se detectaron anticuerpos contra los serotipos A, O, SAT 1 y SAT 2.
Palabras clave
Chad – Fiebre aftosa – Ganado vacuno – Seroprevalencia – Serotipo – Virus.
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